| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Susan M. Ramin | Q110252023 |
| P2093 | author name string | Yang Xia | |
| Rodney E Kellems | |||
| Cissy Chenyi Zhou | |||
| P2860 | cites work | AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration | Q24290268 |
| Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. | Q24537348 | ||
| Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis | Q28589061 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Insulin receptor antibodies inhibit insulin uptake by the liver: in vivo 123I-insulin scintigraphic scanning and in vitro characterization in autoimmune hypoglycemia | Q32056639 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Preeclampsia: what we know and what we do not know | Q33858363 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
| Dimerization of G-protein-coupled receptors: roles in signal transduction | Q35592680 | ||
| Thyroid-stimulating hormone receptor and its role in Graves' disease | Q35599869 | ||
| Roles of G-protein-coupled receptor dimerization | Q35622424 | ||
| G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling | Q35625502 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Genetic progress towards the molecular basis of autoimmunity. | Q36368037 | ||
| Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. | Q36548874 | ||
| The immune system and happiness. | Q36617511 | ||
| Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
| Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia | Q40530224 | ||
| Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation | Q40735093 | ||
| Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy | Q40841949 | ||
| Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction | Q43744794 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion | Q46877931 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award | Q48348609 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q56619493 | ||
| Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia | Q56619500 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia | Q58778301 | ||
| Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension | Q71662795 | ||
| Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops | Q71694608 | ||
| Alpha 1-adrenergic receptor antibodies in patients with primary hypertension | Q73089177 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects | Q74589807 | ||
| Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences | Q79260245 | ||
| Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature | Q79616522 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 3391-5 | |
| P577 | publication date | 2007-09-15 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Angiotensin receptors, autoimmunity, and preeclampsia | |
| P478 | volume | 179 |
| Q35701236 | Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice |
| Q28534198 | Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A |
| Q35681804 | Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q35930887 | Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm Labor |
| Q39198610 | Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase |
| Q35236547 | Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia |
| Q89454188 | Lipoxin A4 suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1 |
| Q64108020 | Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications |
| Q35053657 | Maternal treatment with agonistic autoantibodies against type-1 angiotensin II receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats |
| Q37785245 | Polycystic ovary syndrome and autoimmunity |
| Q37362662 | Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
| Q26828020 | Role of endothelin in uteroplacental circulation and fetal vascular function |
| Q33834419 | The role of inflammation in the pathology of preeclampsia |
| Q44770951 | Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation |
| Q82893732 | Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy |
Search more.